/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...
December S&P 500 futures (ESZ22) are trending down -0.17% this morning after three major US benchmark indices ended the previous week at 3-month lows as fears grew that raising interest rates to combat...
Morning Markets December S&P 500 futures (ESZ22 ) this morning are down by -1.21% at a 2-month low. Stock indexes this morning are extending this week’s sell-off on concern that the Fed’s resolve to...
December S&P 500 futures (ESZ22) are trending down -0.58% this morning after three major US benchmark indices ended in the red for a third straight trading session as investors reacted to the Federal Reserve's...
Spero Therapeutics, Inc. (NASDAQ: SPRO) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research, development and
A Massachusetts-based %Biotech firm is grabbing the attention of traders across the board during Thursday’s premarket after it was announced that the company has entered into an exclusive license agreement...
December S&P 500 futures (ESZ22) are trending up +0.49% this morning after three major US benchmark indices jolted up and down before plunging in the final 30 minutes of trading to close Wednesday in the...
Initiation of a Placebo-controlled Phase 2 Trial of SPR720 in Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Expected in 4Q 2022 Initiation of...
CAMBRIDGE, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced that it will host a conference call and live...
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Spero Therapeutics, Inc. ("Spero" or the "Company") (NASDAQ: SPRO)...